Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-03

Clinical Trial Update: Studies of Neuregulin/ERBB Signaling in Human Heart

View source ↗

Summary

This clinical trial update notes ongoing recruitment for studies on neuregulin/ERBB signaling in the human heart, with indications including heart disease, vasc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Neuregulin-1 (neuregulin-1)

Snippet

Sponsor: Douglas B. Sawyer | Conditions: Heart Disease, Vascular Disease | Status: RECRUITING